Back to Search
WILLIAM ALBRECHT, PH.D
PH.D
Clinical Psychologist
NPI: 1528029022IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
2474(NC)
Education
OTHER
Class of 1997
Research & Publications (20)
In vitro metabolism of 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl] acetic acid (licofelone, ML3000), an inhibitor of cyclooxygenase-1 and -2 and 5-lipoxygenase.
PMID 18268076·Drug Metab Dispos·2008
7-preclinical
Influence of p38MAPK inhibition on IL-1beta-stimulated human chondrocytes: a microarray approach.
PMID 19360329·Int J Mol Med·2009
8-other
Novel polymer blends for the preparation of membranes for biohybrid liver systems.
PMID 19323892·J Biomater Sci Polym Ed·2009
8-other
Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891).
PMID 18191322·Eur Urol·2008
4-observational
Poly(ether imide) membranes: studies on the effect of surface modification and protein pre-adsorption on endothelial cell adhesion, growth and function.
PMID 18544233·J Biomater Sci Polym Ed·2008
8-other
Words of wisdom. Re: a 5-year follow-up study of asymptomatic men with testicular microlithiasis.
PMID 19051380·Eur Urol·2008
8-other
Editorial comment on: continuous versus six months a year maximal androgen blockade in the management of prostate cancer: a randomised study.
PMID 18339476·Eur Urol·2008
8-other
Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1.
PMID 18550688·J Pharmacol Exp Ther·2008
4-observational
Hemocompatibility of poly(ether imide) membranes functionalized with carboxylic groups.
PMID 18452029·J Mater Sci Mater Med·2008
4-observational
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.
PMID 18191015·Eur Urol·2008
8-other
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.
PMID 18191324·Eur Urol·2008
6-review
Membranes from acrylonitrile-based polymers for selective cultivation of human keratinocytes.
PMID 17941802·Tissue Eng·2007
8-other
A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer.
PMID 17509302·J Urol·2007
3-trial
A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
PMID 17140723·Eur Urol·2007
3-trial
In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MS.
PMID 17624026·Xenobiotica·2007
7-preclinical
Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor.
PMID 17344341·Drug Metab Dispos·2007
4-observational
Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891.
PMID 16622261·J Clin Oncol·2006
4-observational
Poly(ether imide) membranes modified with poly(ethylene imine) as potential carriers for epidermal substitutes.
PMID 16565943·Macromol Biosci·2006
8-other
Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry.
PMID 16944926·J Proteome Res·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2459 EMERALD PL
GREENVILLE, NC 27834 - Phone
- (252) 757-3939
Quick Facts
- NPI
- 1528029022
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile